Zilganersen Expanded Access Program for Individuals With Alexander Disease

Summary

The purpose of the expanded access program (EAP) is to provide access to zilganersen for eligible individuals with Alexander disease (AxD).

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications